Patrick Hwu: Honored to be the keynote speaker at BioFlorida, Inc.’s conference

Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post by BioFlorida, Inc. on LinkedIn, adding:

“Honored to be the keynote speaker at BioFlorida, Inc.’s conference on Nov. 19 in Orlando, Florida!

The conference brings together leaders in the biotech and life sciences sectors to share insights and foster collaboration across Florida’s thriving biopharmaceutical landscape.

See their post below for all the details on how to register.”

Quoting BioFlorida, Inc:

” Conference Keynote Announcement

Tuesday, November 19, 2024
Patrick Hwu, M.D. – President & CEO – Moffitt Cancer Center

MEET THE KEYNOTE:
Patrick Hwu, MD, is the President and CEO of Moffitt Cancer Center one of the nation’s leading cancer hospitals and the only National Cancer Institute-designated comprehensive cancer center based in Florida.

As an internationally recognized tumor immunologist, Dr. Hwu has led pioneering research and clinical efforts to better understand the interactions between tumors and the immune system. He helped launch the field of gene modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. His work focuses on vaccines, adoptive T-cell therapies and immune resistance. An internationally recognized physician scientist, Dr. Hwu has a proven track record leading collaborative teams to make breakthroughs in science while improving cancer outcomes for cancer patients.

Prior to joining Moffitt, Dr. Hwu was the head of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, where he held various leadership roles for 17 years. In 2003, he was recruited as the first chairman of the Department of Melanoma Medical Oncology. He was also the associate director of the Center for Cancer Immunology Research (2004) and chair of the Department of Sarcoma Medical Oncology (2012).

Dr. Hwu earned his medical degree from The Medical College of Pennsylvania. He served as a house officer in Internal Medicine at The Johns Hopkins Hospital and completed a fellowship in oncology at the National Cancer Institute (NCI), where he worked as a principal investigator leading tumor immunology studies.

Plan Ahead!
Last year’s conference saw over 515 participants and 50+ exhibitors. This year promises to be even bigger with:
– Streamlined programming representing Florida’s life science ecosystem.
– High-level keynotes from industry leaders.
– Enhanced BIOPITCH program ($100K in award prizes, 3 categories)
– Extended networking sessions to build meaningful connections.
– A “Connection Corridor” dedicated to exhibitors and sponsors.
– Secure your exhibit spot today, remaining availability is extremely limited!

Don’t Miss Out!
– Conference registration.
– Hotel room.
– Exhibit & Sponsor.
– Award Nominations (closes this Friday, November 1st).

For questions or assistance please contact us at [email protected] or 561.653.3839.

We look forward to seeing you at this must-attend event and witnessing the next wave of life science innovation!”

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.